Panza, Francesco

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 122

Circulating Biomarkers of Cognitive Decline and Dementia

Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 120

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

NCD Risk Factor Collaboration (NCD-RisC), Zhou, B., Sheffer, K. E., Bennett, J. E., Gregg, E. W., Danaei, G., Singleton, R. K., Shaw, J. E., Mishra, A., Lhoste, V. P. F., et al. (2023) · Nature Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 94

BACE inhibitors in clinical development for the treatment of Alzheimer’s disease

Panza, F., Lozupone, M., Solfrizzi, V., Sardone, R., Piccininni, C., Dibello, V., Stallone, R., Giannelli, G., Bellomo, A., Greco, A., et al. (2018) · Expert Review of Neurotherapeutics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 92

Information and Communication Technologies for the Activities of Daily Living in Older Patients with Dementia: A Systematic Review

D’Onofrio, G., Sancarlo, D., Ricciardi, F., Panza, F., Seripa, D., Cavallo, F., Giuliani, F., & Greco, A. (2017) · Journal of Alzheimer’s Disease

Technology Use by Older AdultsDementia and Cognitive Impairment Research

Cited by 79

Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs

Lozupone, M., Solfrizzi, V., D’Urso, F., Di Gioia, I., Sardone, R., Dibello, V., Stallone, R., Liguori, A., Ciritella, C., Daniele, A., et al. (2020) · Expert Opinion on Emerging Drugs

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 77

Diminishing benefits of urban living for children and adolescents' growth and development

NCD Risk Factor Collaboration (NCD-RisC), Mishra, A., Zhou, B., Rodriguez-Martinez, A., Bixby, H., Singleton, R. K., Carrillo-Larco, R. M., Sheffer, K. E., Paciorek, C. J., Bennett, J. E., et al. (2023) · Nature

Obesity, Physical Activity, DietHuman Health and Disease

Cited by 70

Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

Solfrizzi, V., and for the Italian Longitudinal Study on Aging Working Group 2, Panza, F., Imbimbo, B. P., D’Introno, A., Galluzzo, L., Gandin, C., Misciagna, G., Guerra, V., Osella, A., et al. (2015) · Journal of Alzheimer s Disease

Coffee research and impactsDementia and Cognitive Impairment Research

Cited by 65

Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease

Dalmasso, M. C., Brusco, L. I., Olivar, N., Muchnik, C., Hanses, C., Milz, E., Becker, J., Heilmann-Heimbach, S., Hoffmann, P., Prestia, F. A., et al. (2019) · Translational Psychiatry

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 51

Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium

Seripa, D., Solfrizzi, V., Imbimbo, B. P., Daniele, A., Santamato, A., Lozupone, M., Zuliani, G., Greco, A., Logroscino, G., & Panza, F. (2016) · Expert Review of Neurotherapeutics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 50

The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset

Panza, F., Seripa, D., Lozupone, M., Solfrizzi, V., Imbimbo, B. P., Barulli, M. R., Tortelli, R., Capozzo, R., Bisceglia, P., Dimitri, A., et al. (2018) · Expert Opinion on Biological Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 41

Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory)

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 35

Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?

Vecchio, F. L., Bisceglia, P., Imbimbo, B. P., Lozupone, M., Latino, R. R., Resta, E., Leone, M., Solfrizzi, V., Greco, A., Daniele, A., et al. (2022) · Therapeutic Advances in Chronic Disease

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 28

Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?

Veneziani, F., Panza, F., Solfrizzi, V., Capozzo, R., Barulli, M. R., Leo, A., Lozupone, M., Fontana, A., Arcuti, S., Copetti, M., et al. (2016) · International Psychogeriatrics

Dementia and Cognitive Impairment ResearchInnovations in Medical Education

Cited by 27

The challenges of anti-tau therapeutics in Alzheimer disease

Panza, F., & Lozupone, M. (2022) · Nature Reviews Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 23

Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease

D’Introno, A., Solfrizzi, V., Colacicco, A. M., Capurso, C., Amodio, M., Todarello, O., Capurso, A., Kehoe, P. G., & Panza, F. (2006) · Neurobiology of Aging

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 23

Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies

Panza, F., Dibello, V., Sardone, R., Castellana, F., Zupo, R., Lampignano, L., Bortone, I., Stallone, R., Cirillo, N., Damiani, C., et al. (2023) · Expert Opinion on Investigational Drugs

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 22

Social determinants of late-life depression epigenetics

Lozupone, M., & Panza, F. (2020) · Epigenomics

Epigenetics and DNA MethylationHealth disparities and outcomes

Cited by 15